NIBN

Venture Capital Be'er Sheva, Israel Est. 2009
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
across known amounts
Stages

About

The NIBN provides its researchers with state-of-the-art laboratories, research and manpower grants, infrastructure support units, as well as intellectual property strategy and guidance, project management, business development leadership and legal services provided by NIBNs experienced professional management team. The National Institute for Biotechnology in the Negev Ltd. (NIBN), a unique Bio accelerator located within Ben-Gurion University of the Negev (BGU), is the first self-organized, independent research entity established under the auspices of a University in Israel. The NIBN was established as a company in November 2009 and its shareholders are BGU and the de Picciotto family. NIBN is the home for accelerating BGUs bio-applied translational discovery and research, through successful proof-of-concept and commercialization.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is NIBN's primary focus and operational structure?
NIBN, the National Institute for Biotechnology in the Negev Ltd., is a unique Bio accelerator located within Ben-Gurion University of the Negev (BGU). Established in November 2009, it functions as an independent research entity accelerating BGU's bio-applied translational discovery and research through proof-of-concept and commercialization.
Who are the shareholders of NIBN?
NIBN's shareholders are Ben-Gurion University of the Negev (BGU) and the de Picciotto family.
What services does NIBN provide to its researchers?
NIBN provides state-of-the-art laboratories, research and manpower grants, infrastructure support units, intellectual property strategy and guidance, project management, business development leadership, and legal services.
What specific areas of biotechnology does NIBN focus on?
NIBN focuses on areas including inflammatory diseases, autoimmune diseases, oncology, drug discovery, vaccines development, therapeutics, cell therapy, biopharmaceutical, rare diseases, agtech, pharmaceuticals, and targeted therapy.
When was NIBN established?
NIBN was established as a company in November 2009.
Where is NIBN headquartered?
NIBN is headquartered in Be'er Sheva, Israel.